Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Other financing activities (2020 - 2022)

Edesa Biotech's Other financing activities history spans 3 years, with the latest figure at $406.0 for Q3 2022.

  • For Q3 2022, Other financing activities rose 100.25% year-over-year to $406.0; the TTM value through Sep 2022 reached $328059.0, up 74.16%, while the annual FY2025 figure was $215157.0, N/A changed from the prior year.
  • Other financing activities for Q3 2022 was $406.0 at Edesa Biotech, down from $268990.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $468699.0 in Q1 2020 and bottomed at -$161042.0 in Q3 2021.
  • The 3-year median for Other financing activities is $50301.5 (2020), against an average of $124018.1.
  • The largest annual shift saw Other financing activities crashed 2393.72% in 2021 before it surged 100.25% in 2022.
  • A 3-year view of Other financing activities shows it stood at $41940.0 in 2020, then skyrocketed by 39.87% to $58663.0 in 2021, then plummeted by 99.31% to $406.0 in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Other financing activities are $406.0 (Q3 2022), $268990.0 (Q1 2022), and $58663.0 (Q4 2021).